Journal article Open Access

IMPACT OF CLINICAL PHARMACIST CARE ON QUALITY OF LIFE IN CERVICAL CANCER PATIENTS ON CHEMORADIATION

N.Tejaswi1*, Y.Triveni1, M.Indira Priyadarshini1, Dr.A.Satish Kumar2, P.Sharmila Nirojini1, M.Maneesh Kumar1, Prof.Rama Rao Nadendla1


DCAT Export

<?xml version='1.0' encoding='utf-8'?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:adms="http://www.w3.org/ns/adms#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dct="http://purl.org/dc/terms/" xmlns:dctype="http://purl.org/dc/dcmitype/" xmlns:dcat="http://www.w3.org/ns/dcat#" xmlns:duv="http://www.w3.org/ns/duv#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:frapo="http://purl.org/cerif/frapo/" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:gsp="http://www.opengis.net/ont/geosparql#" xmlns:locn="http://www.w3.org/ns/locn#" xmlns:org="http://www.w3.org/ns/org#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:prov="http://www.w3.org/ns/prov#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:schema="http://schema.org/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:vcard="http://www.w3.org/2006/vcard/ns#" xmlns:wdrs="http://www.w3.org/2007/05/powder-s#">
  <rdf:Description rdf:about="https://doi.org/10.5281/zenodo.1036512">
    <dct:identifier rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://doi.org/10.5281/zenodo.1036512</dct:identifier>
    <foaf:page rdf:resource="https://doi.org/10.5281/zenodo.1036512"/>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>N.Tejaswi1*, Y.Triveni1, M.Indira Priyadarshini1, Dr.A.Satish Kumar2, P.Sharmila Nirojini1, M.Maneesh Kumar1, Prof.Rama Rao Nadendla1</foaf:name>
        <foaf:givenName>Y.Triveni1, M.Indira Priyadarshini1, Dr.A.Satish Kumar2, P.Sharmila Nirojini1, M.Maneesh Kumar1, Prof.Rama Rao Nadendla1</foaf:givenName>
        <foaf:familyName>N.Tejaswi1*</foaf:familyName>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>1Department of Pharmacy Practice, Chalapathi Institute of Pharmaceutical Sciences, Lam, Guntur. 2Department of Radiotherapy, Government General Hospital, Guntur.</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:title>IMPACT OF CLINICAL PHARMACIST CARE ON QUALITY OF LIFE IN CERVICAL CANCER PATIENTS ON CHEMORADIATION</dct:title>
    <dct:publisher>
      <foaf:Agent>
        <foaf:name>Zenodo</foaf:name>
      </foaf:Agent>
    </dct:publisher>
    <dct:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#gYear">2017</dct:issued>
    <dcat:keyword>Quality Of Life, Cervical Cancer, Radiotherapy, Chemotherapy.</dcat:keyword>
    <dct:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2017-08-30</dct:issued>
    <owl:sameAs rdf:resource="https://zenodo.org/record/1036512"/>
    <adms:identifier>
      <adms:Identifier>
        <skos:notation rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://zenodo.org/record/1036512</skos:notation>
        <adms:schemeAgency>url</adms:schemeAgency>
      </adms:Identifier>
    </adms:identifier>
    <dct:isVersionOf rdf:resource="https://doi.org/10.5281/zenodo.1036511"/>
    <dct:isPartOf rdf:resource="https://zenodo.org/communities/iajpr"/>
    <dct:description>&lt;p&gt;The aim of the study was to evaluate the impact of clinical pharmacist care on Quality of life in cervical cancer patients treated with either Radiotherapy alone or in combination with Chemotherapy. An observational prospective study was conducted over a period of 6 months i.e., from January to July 2016 in the Department of Radiotherapy, GGH, Guntur. The EORTC QLQ-C30 3.0 version, EORTC QLQ CX24 was used to assess the patients quality of life at three different stages i.e., before, after treatment &amp;amp; during follow up. Patients were counseled about disease, therapy &amp;amp; its side effects management. The results were evaluated using one way ANOVA, unpaired t test in graph pad prism version (5.04).A total of 66 patients were enrolled in the study. The mean score of global health of cervical cancer patients during follow up was 85.66±12.26, which was significantly higher than the before treatment score 45.88±12.24 (P value &amp;lt;0.0001).There was also significant improvement in functional domain scales like physical function, role function, emotional function, social function and cognitive function. Mean symptoms score at follow up was 6.90 ±23.03 was declined compared to before treatment scores 31.93±23.5 (P value &amp;lt;0.0001). Patients complain of substantial decline in sexual activity post radiotherapy. There was a significant improvement in quality of life in cervical carcinoma patients after treatment with radiotherapy and chemotherapy along with clinical pharmacist counseling.&lt;/p&gt;</dct:description>
    <dct:accessRights rdf:resource="http://publications.europa.eu/resource/authority/access-right/PUBLIC"/>
    <dct:accessRights>
      <dct:RightsStatement rdf:about="info:eu-repo/semantics/openAccess">
        <rdfs:label>Open Access</rdfs:label>
      </dct:RightsStatement>
    </dct:accessRights>
    <dct:license rdf:resource="https://creativecommons.org/licenses/by/4.0/legalcode"/>
    <dcat:distribution>
      <dcat:Distribution>
        <dcat:accessURL rdf:resource="https://doi.org/10.5281/zenodo.1036512"/>
        <dcat:byteSize>787926</dcat:byteSize>
        <dcat:downloadURL rdf:resource="https://zenodo.org/record/1036512/files/22.pdf"/>
        <dcat:mediaType>application/pdf</dcat:mediaType>
      </dcat:Distribution>
    </dcat:distribution>
  </rdf:Description>
</rdf:RDF>
100
102
views
downloads
All versions This version
Views 100100
Downloads 102102
Data volume 80.4 MB80.4 MB
Unique views 9090
Unique downloads 9898

Share

Cite as